Synthesis and anti-trypanosoma cruzi activity of 3-cyanopyridine derivatives.
SLAFER, Brian Wayne; DESSOY, Marco Aurélio; OLIVEIRA, Ramon Guerra de; MOLLO, María Cruz; LEE, Eun; MATHEEUSSEN, An; MAES, Louis; CALJON, Guy; FERREIRA, Leonardo Luiz Gomes; KROGH, Renata; ANDRICOPULO, Adriano Defini; CRUZ, Luiza dos Reis; MOWBRAY, Charles E.; KRATZ, Jadel M.; DIAS, Luiz Carlos.
SLAFER, Brian Wayne; DESSOY, Marco Aurélio; OLIVEIRA, Ramon Guerra de; MOLLO, María Cruz; LEE, Eun; MATHEEUSSEN, An; MAES, Louis; CALJON, Guy; FERREIRA, Leonardo Luiz Gomes; KROGH, Renata; ANDRICOPULO, Adriano Defini; CRUZ, Luiza dos Reis; MOWBRAY, Charles E.; KRATZ, Jadel M.; DIAS, Luiz Carlos.
Abstract: Chagas disease (CD) is a parasitic neglected tropical disease (NTD) caused by the protozoan Trypanosoma cruzi that affects 6 million people worldwide, often resulting in financial burden, morbidity, and mortality in endemic regions. Given a lack of highly efficient and safe treatments, new, affordable, and fit-for-purpose drugs for CD are urgently needed. In this work, we present a hit-to-lead campaign for novel cyanopyridine analogues as antichagasic agents. In a phenotypic screening against intracellular T. cruzi, hits 1 and 2 were identified and displayed promising potency combined with balanced physicochemical properties. As part of the Lead Optimization Latin America consortium, a set of 40 compounds was designed, synthesized, and tested against T. cruzi intracellular amastigotes and relevant human cell lines. The structural modifications were focused on three positions: cyanopyridine core, linker, and right-hand side. The ADME properties of selected compounds, lipophilicity, kinetic solubility, permeability, and liver microsomal stability, were evaluated. Compounds 1-9 displayed good potency (EC50 T. cruzi amastigote <1 µM), and most compounds did not present significant cytotoxicity (CC50 MRC-5 = 32-64 µM). Despite the good balance between potency and selectivity, the antiparasitic activity of the series appeared to be driven by lipophilicity, making the progression of the series unfeasible due to poor ADME properties and potential promiscuity issues.
@article={003196170,author = {SLAFER, Brian Wayne; DESSOY, Marco Aurélio; OLIVEIRA, Ramon Guerra de; MOLLO, María Cruz; LEE, Eun; MATHEEUSSEN, An; MAES, Louis; CALJON, Guy; FERREIRA, Leonardo Luiz Gomes; KROGH, Renata; ANDRICOPULO, Adriano Defini; CRUZ, Luiza dos Reis; MOWBRAY, Charles E.; KRATZ, Jadel M.; DIAS, Luiz Carlos.},title={Synthesis and anti-trypanosoma cruzi activity of 3-cyanopyridine derivatives},journal={ACS Omega},note={v. 9, n. 20, p. 22360-22370 + supporting information},year={2024}}